Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,979 | 18 | 87.5% |
| Education | $282.97 | 3 | 12.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $483.72 | 5 | $0 (2024) |
| GENZYME CORPORATION | $393.12 | 3 | $0 (2023) |
| Gilead Sciences, Inc. | $372.65 | 4 | $0 (2023) |
| SERVIER PHARMACEUTICALS LLC | $288.84 | 3 | $0 (2022) |
| Seagen Inc. | $249.99 | 2 | $0 (2023) |
| BeiGene USA, Inc. | $125.00 | 1 | $0 (2022) |
| Karyopharm Therapeutics Inc. | $123.23 | 1 | $0 (2022) |
| Rigel Pharmaceuticals, Inc. | $121.43 | 1 | $0 (2022) |
| Adaptive Biotechnologies Corporation | $103.82 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25.54 | 1 | ABBVIE INC. ($25.54) |
| 2023 | $976.30 | 8 | GENZYME CORPORATION ($393.12) |
| 2022 | $1,160 | 11 | SERVIER PHARMACEUTICALS LLC ($288.84) |
| 2021 | $99.99 | 1 | AbbVie Inc. ($99.99) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/31/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $25.54 | General |
| 06/15/2023 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 05/30/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $136.51 | General |
| 05/02/2023 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONC | ||||||
| 04/27/2023 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $125.20 | General |
| Category: ONCOLOGY | ||||||
| 03/22/2023 | ABBVIE INC. | VENCLEXTA (Drug) | Education | In-kind items and services | $82.99 | General |
| Category: ONCOLOGY | ||||||
| 02/28/2023 | GENZYME CORPORATION | ENJAYMO (Biological) | Food and Beverage | In-kind items and services | $112.61 | General |
| Category: Hematology | ||||||
| 02/06/2023 | Seagen Inc. | — | Education | In-kind items and services | $99.99 | General |
| 02/02/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $144.00 | General |
| Category: Oncology | ||||||
| 11/16/2022 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Oncology | ||||||
| 10/19/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 09/28/2022 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | In-kind items and services | $103.82 | General |
| Category: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA | ||||||
| 09/14/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONC | ||||||
| 08/04/2022 | SERVIER PHARMACEUTICALS LLC | ONCASPAR (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Oncology | ||||||
| 07/01/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: ONC | ||||||
| 06/23/2022 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $123.23 | General |
| Category: Oncology | ||||||
| 05/11/2022 | SERVIER PHARMACEUTICALS LLC | ONCASPAR (Drug) | Food and Beverage | In-kind items and services | $160.71 | General |
| Category: Oncology | ||||||
| 05/11/2022 | SERVIER PHARMACEUTICALS LLC | ASPARLAS (Drug) | Food and Beverage | In-kind items and services | $112.50 | General |
| Category: Oncology | ||||||
| 04/21/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: ONC | ||||||
| 03/22/2022 | Rigel Pharmaceuticals, Inc. | Tavalisse (Drug) | Food and Beverage | In-kind items and services | $121.43 | General |
| Category: Hematology | ||||||
| 05/12/2021 | AbbVie Inc. | VENCLEXTA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 25 | 32 | $32,338 | $3,198 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 17 | $19,548 | $2,033 | 10.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 15 | $12,790 | $1,165 | 9.1% |
About David Levitz
David Levitz is a Internal Medicine healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2017. The National Provider Identifier (NPI) number assigned to this provider is 1629508759.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Levitz has received a total of $2,262 in payments from pharmaceutical and medical device companies, with $25.54 received in 2024. These payments were reported across 21 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,979).
As a Medicare-enrolled provider, Levitz has provided services to 25 Medicare beneficiaries, totaling 32 services with total Medicare billing of $3,198. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Bronx, NY
- Active Since 06/12/2017
- Last Updated 04/10/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1629508759
Products in Payments
- VENCLEXTA (Drug) $458.18
- Trodelvy (Drug) $372.65
- ONCASPAR (Drug) $176.34
- TUKYSA (Drug) $150.00
- SARCLISA (Biological) $144.00
- BRUKINSA (Drug) $125.00
- XPOVIO (Drug) $123.23
- Tavalisse (Drug) $121.43
- ENJAYMO (Biological) $112.61
- ASPARLAS (Drug) $112.50
- clonoSEQ (Device) $103.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bronx
Timothy Kanter, M.d, M.D
Internal Medicine — Payments: $865,160
Dr. Jason Leider, M.d, M.D
Internal Medicine — Payments: $759,257
Bulent Atac, Md, MD
Internal Medicine — Payments: $654,500
Shervin Mortazavi, M.d, M.D
Internal Medicine — Payments: $402,598
Dr. Elizabeth Jenny-Avital
Internal Medicine — Payments: $176,355
Vivek Gumaste, M.d, M.D
Internal Medicine — Payments: $163,229